{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T09:26:27Z","timestamp":1747128387447},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives:<\/jats:title>\n                  <jats:p>Prostate cancer screening algorithms and preoperative nomograms do not include patients\u2019 body mass index (BMI). We evaluated outcomes at radical prostatectomy (RP) adjusted to BMI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>Serum prostate-specific antigen (PSA) levels, PSA mass, PSA density (PSAD), and RP findings were analyzed with respect to BMI in 4,926 men who underwent RP between 2005 and 2014.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>In total, 1,001 (20.3%) men were normal weight, 2,547 (51.7%) were overweight, and 1,378 (28%) were obese. Median PSA levels (ng\/mL) were normal weight, 5.0; overweight, 5.1; and obese, 5.2 (P = .094). Median PSA mass increased with increasing BMI: 15.9 vs 17.4 vs 19.4 \u03bcg (P &amp;lt; .001). Median PSAD was not significantly different: 0.11 vs 0.11 vs 0.11 ng\/mL\/g (P = .084). Median prostate weight increased with increasing BMI: 44 vs 45 vs 49 g (P &amp;lt; .001). Median prostatectomy tumor volume increased with increasing BMI: 3.9 vs 4.7 vs 5.9 cm3 (P &amp;lt; .001). Overweight and obese patients had a higher Gleason score and more locally advanced cancer (P &amp;lt; .001). Frequency of positive surgical margins increased with higher BMIs (P &amp;lt; .001). Frequency of lymph node metastasis did not differ significantly (P = .088).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>While BMI correlates with tumor volume, Gleason score, and extent of disease at RP, there is no routinely measured clinical parameter reflecting this. Only PSA mass highlights this correlation. Thus, BMI and potentially PSA mass should be taken into account in predictive algorithms pertaining to prostate cancer and its surgical treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1309\/ajcpql9mkq6vddwl","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T12:48:53Z","timestamp":1437050933000},"page":"271-277","source":"Crossref","is-referenced-by-count":17,"title":["Correlation of High Body Mass Index With More Advanced Localized Prostate Cancer at Radical Prostatectomy Is Not Reflected in PSA Level and PSA Density but Is Seen in PSA Mass"],"prefix":"10.1093","volume":"144","author":[{"given":"Oleksandr N.","family":"Kryvenko","sequence":"first","affiliation":[{"name":"Departments of Pathology and Urology, University of Miami Miller School of Medicine, Miami, FL"},{"name":"Department of Pathology, Henry Ford Hospital, Detroit, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan I.","family":"Epstein","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Urology, and Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick A.","family":"Meier","sequence":"additional","affiliation":[{"name":"Department of Pathology, Henry Ford Hospital, Detroit, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilesh S.","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Pathology, Henry Ford Hospital, Detroit, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mani","family":"Menon","sequence":"additional","affiliation":[{"name":"Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireya","family":"Diaz","sequence":"additional","affiliation":[{"name":"Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,8,1]]},"reference":[{"key":"2021052713505354300_b1-1440271","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jama.1993.03510070082041","article-title":"Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges","volume":"270","author":"Oesterling","year":"1993","journal-title":"JAMA"},{"key":"2021052713505354300_b2-1440271","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.juro.2013.04.119","article-title":"Early detection of prostate cancer: AUA guideline","volume":"190","author":"Carter","year":"2013","journal-title":"J Urol"},{"key":"2021052713505354300_b3-1440271","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/jnci\/djj410","article-title":"Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability","volume":"98","author":"Carter","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"2021052713505354300_b4-1440271","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0090-4295(94)80260-2","article-title":"Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma","volume":"43","author":"Bazinet","year":"1994","journal-title":"Urology"},{"key":"2021052713505354300_b5-1440271","first-page":"102","article-title":"Percent free PSA as an additional measure in a prostate cancer screen","volume":"14","author":"Miele","year":"2001","journal-title":"Clin Lab Sci"},{"key":"2021052713505354300_b6-1440271","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0090-4295(02)02524-4","article-title":"Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digital rectal examination","volume":"61","author":"Uzzo","year":"2003","journal-title":"Urology"},{"key":"2021052713505354300_b7-1440271","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1309\/AJCPWIZ9X2DMBEBM","article-title":"Findings in 12-core transrectal ultrasound-guided prostate needle biopsy that predict more advanced cancer at prostatectomy: analysis of 388 biopsy-prostatectomy pairs","volume":"137","author":"Kryvenko","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"2021052713505354300_b8-1440271","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1097\/01.ju.0000091805.98960.13","article-title":"A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer","volume":"170","author":"Cagiannos","year":"2003","journal-title":"J Urol"},{"key":"2021052713505354300_b9-1440271","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-5347(17)35410-1","article-title":"The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer","volume":"150","author":"Partin","year":"1993","journal-title":"J Urol"},{"key":"2021052713505354300_b10-1440271","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","article-title":"Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study","volume":"335","author":"Reeves","year":"2007","journal-title":"BMJ"},{"key":"2021052713505354300_b11-1440271","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s11255-012-0207-z","article-title":"Impact of body mass index and tumor location on the incidence of benign histology at the time of nephron-sparing surgery","volume":"44","author":"Kava","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"2021052713505354300_b12-1440271","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1464-410X.2012.11611.x","article-title":"Prognostic Gleason grade grouping: data based on the modified Gleason scoring system","volume":"111","author":"Pierorazio","year":"2013","journal-title":"BJU Int"},{"key":"2021052713505354300_b13-1440271","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/01.ju.0000152408.25738.23","article-title":"Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE","volume":"173","author":"Kane","year":"2005","journal-title":"J Urol"},{"key":"2021052713505354300_b14-1440271","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","article-title":"The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma","volume":"29","author":"Epstein","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"2021052713505354300_b15-1440271","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5858\/2006-130-303-KIIHAR","article-title":"Key issues in handling and reporting radical prostatectomy specimens","volume":"130","author":"Srigley","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"2021052713505354300_b16-1440271","unstructured":"World Health Organization\n          . Global database on body mass index. http:\/\/apps.who.int\/bmi\/index.jsp?introPage=intro_3.html. Accessed May 25, 2015."},{"key":"2021052713505354300_b17-1440271","doi-asserted-by":"crossref","first-page":"CR104","DOI":"10.12659\/MSM.881395","article-title":"PSA mass as a marker of prostate cancer progression after radical prostatectomy","volume":"17","author":"Bryniarski","year":"2011","journal-title":"Med Sci Monitor"},{"key":"2021052713505354300_b18-1440271","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.1994.03510290050036","article-title":"Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer","volume":"271","author":"Epstein","year":"1994","journal-title":"JAMA"},{"key":"2021052713505354300_b19-1440271","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.juro.2013.06.021","article-title":"Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men","volume":"191","author":"Sundi","year":"2014","journal-title":"J Urol"},{"key":"2021052713505354300_b20-1440271","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.urology.2013.12.054","article-title":"Biopsy criteria for determining appropriateness for active surveillance in the modern era","volume":"83","author":"Kryvenko","year":"2014","journal-title":"Urology"},{"key":"2021052713505354300_b21-1440271","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1464-410X.2011.10453.x","article-title":"Influence of obesity on tumour volume in patients with prostate cancer","volume":"109","author":"Capitanio","year":"2012","journal-title":"BJU Int"},{"key":"2021052713505354300_b22-1440271","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.eururo.2006.10.055","article-title":"Vattikuti Institute prostatectomy: contemporary technique and analysis of results","volume":"51","author":"Menon","year":"2007","journal-title":"Eur Urol"},{"key":"2021052713505354300_b23-1440271","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1097\/01.ju.0000067464.53313.dd","article-title":"Vattikuti Institute prostatectomy: technique","volume":"169","author":"Menon","year":"2003","journal-title":"J Urol"},{"key":"2021052713505354300_b24-1440271","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PAS.0b013e318185723e","article-title":"Detection of cancer in radical prostatectomy specimens with no residual carcinoma in the initial review of slides","volume":"33","author":"Duffield","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"2021052713505354300_b25-1440271","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0090-4295(01)01441-8","article-title":"Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium","volume":"58","author":"Partin","year":"2001","journal-title":"Urology"},{"key":"2021052713505354300_b26-1440271","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.urology.2007.11.049","article-title":"Body composition and serum prostate-specific antigen: review and findings from Flint Men\u2019s Health Study","volume":"71","author":"Beebe-Dimmer","year":"2008","journal-title":"Urology"},{"key":"2021052713505354300_b27-1440271","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.urology.2007.11.036","article-title":"Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic","volume":"71","author":"Price","year":"2008","journal-title":"Urology"},{"key":"2021052713505354300_b28-1440271","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/cncr.22249","article-title":"Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men","volume":"107","author":"Fowke","year":"2006","journal-title":"Cancer"},{"key":"2021052713505354300_b29-1440271","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1464-410X.2008.07934.x","article-title":"Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases","volume":"102","author":"Freedland","year":"2008","journal-title":"BJU Int"},{"key":"2021052713505354300_b30-1440271","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/bju.12671","article-title":"Gleason inflation 1998\u20132011: a registry study of 97 168 men","volume":"115","author":"Danneman","year":"2015","journal-title":"BJU Int"},{"key":"2021052713505354300_b31-1440271","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1200\/JCO.2004.03.132","article-title":"Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy","volume":"22","author":"Amling","year":"2004","journal-title":"J Clin Oncol"},{"key":"2021052713505354300_b32-1440271","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0022-5347(17)40761-0","article-title":"Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer","volume":"141","author":"Partin","year":"1989","journal-title":"J Urol"},{"key":"2021052713505354300_b33-1440271","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/pcan.2013.27","article-title":"Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: results from two independent nested case-control studies","volume":"16","author":"Parker","year":"2013","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2021052713505354300_b34-1440271","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.298.19.2275","article-title":"Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer","volume":"298","author":"Banez","year":"2007","journal-title":"JAMA"},{"key":"2021052713505354300_b35-1440271","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1158\/1055-9965.EPI-08-0938","article-title":"Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial","volume":"18","author":"Grubb","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2021052713505354300_b36-1440271","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1464-410X.2008.07883.x","article-title":"Variance inflation in sequential calculations of body surface area, plasma volume, and prostate-specific antigen mass","volume":"102","author":"Sivanandam","year":"2008","journal-title":"BJU Int"},{"key":"2021052713505354300_b37-1440271","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/pros.22928","article-title":"Pathologic characteristics of low risk prostate cancer based on totally embedded prostatectomy specimens","volume":"75","author":"Swanson","year":"2015","journal-title":"Prostate"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/144\/2\/271\/38276214\/ajcpath144-0271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/144\/2\/271\/38276214\/ajcpath144-0271.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T01:34:57Z","timestamp":1622165697000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/144\/2\/271\/1766747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,1]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,8,1]]},"published-print":{"date-parts":[[2015,8,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpql9mkq6vddwl","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,8,1]]},"published":{"date-parts":[[2015,8,1]]}}}